Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT
Bone Marrow Transplantation, Published online: 23 October 2019; doi:10.1038/s41409-019-0720-0Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT
Source: Bone Marrow Transplantation - Category: Hematology Authors: Thomas Heinicke Myriam Labopin Emmanuelle Polge Dietger Niederwieser Uwe Platzbecker Henrik Sengelov Goda Choi Jan Cornelissen Didier Blaise J ürgen Kuball Gwendolyn van Gorkom Nicolaas Schaap Victoria Potter Franciane Paul Bipin N. Savani Arnon Nagler M Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Bone Marrow Transplant | Hematology | Leukemia | Nutrition | Stem Cell Therapy | Stem Cells | Study | Transplants